logo
logo
ProAssurance Corporation

ProAssurance Corporation

NYSE•PRA
CEO: Mr. Edward Lewis Rand Jr., CPA
セクター: Financial Services
業種: Insurance - Property & Casualty
上場日: 1991-09-04
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds. The company also provides workers' compensation insurance products, such as guaranteed cost policies, policyholder dividend policies, retrospectively rated policies, and deductible policies, as well as alternative market solutions that include program design, fronting, claims administration, risk management, SPC rental, asset management, and SPC management services for individual companies, agencies, groups, and associations. The company also participates in Syndicate 1729 at Lloyd's of London for underwriting. It markets its products through independent agencies and brokers, as well as an internal business development team. The company was founded in 1976 and is headquartered in Birmingham, Alabama.
連絡先情報
100 Brookwood Place, Birmingham, AL, 35209, United States
205-877-4400
www.proassurance.com
時価総額
$1.26B
PER (TTM)
37.4
11.5
配当利回り
--
52週高値
$24.65
52週安値
$13.90
52週レンジ
99%
順位49Top 66.7%
3.2
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
弱い • 3.2 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

財務ダッシュボード

Q3 2025 データ

売上高

$274.82M-2.02%
直近4四半期の推移

EPS

$0.03-90.63%
直近4四半期の推移

フリーCF

$24.04M+138.74%
直近4四半期の推移

2025 Q3 決算ハイライト

主なハイライト

Strong Equity Position Growth Total Shareholders' Equity reached $1.304B, reflecting an increase of $102.5M compared to December 31, 2024.
Non-GAAP Operating Income Rises Nine-month Non-GAAP Operating Income was $41.474M, showing an $11.048M improvement versus the prior year period.
Investment Income Benefits Yields Net Investment Income totaled $116.326M for nine months, up 8.0% due to higher average book yields across the portfolio.

リスク要因

Consolidated Net Income Drops Nine-month Net Income fell 52.0% to $17.545M compared to $36.575M recognized in the prior year period.
Specialty P&C Loss Ratio Worsens Specialty P&C current accident year net loss ratio rose 0.6 pts to 82.7% for the nine months ended September 30, 2025.
Merger Closing Regulatory Hurdles Doctors Company merger closing remains subject to customary conditions, including pending insurance regulator approvals in key states.

見通し

Merger Closing Anticipated Timeline Company currently anticipates closing the proposed transaction with The Doctors Company by June 30, 2026, pending final reviews.
Foreign Currency Hedging Strategy Management changed hedging strategy in Q1 2025, now utilizing foreign currency forward contracts instead of fixed maturity investments.
MPL Reinsurance Terms Adjusted MPL treaty retention increased to 6% from 0% for risk layers above $2M; workers' compensation treaty renewed at lower rate.

同業比較

売上高 (TTM)

Selective Insurance Group, Inc.SIGI
$5.34B
+9.8%
Navient CorporationNAVI
$3.20B
-24.5%
Root, Inc.ROOT
$1.45B
+38.5%

粗利益率 (最新四半期)

Republic Bancorp, Inc.RBCAA
100.0%
+6.8pp
Selective Insurance Group, Inc.SIGI
100.0%
+0.0pp
Navient CorporationNAVI
88.4%
+316.6pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
SIGI$5.30B11.413.6%6.0%
BFC$1.63B20.08.1%2.8%
DCOM$1.54B13.67.7%2.4%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
-1.1%
横ばい
4四半期純利益CAGR
-55.3%
収益性の低下
キャッシュフロー安定性
25%
キャッシュフローに注意が必要

深度リサーチ

次回決算:2026年2月23日
|
EPS:$0.22
|
売上高:-
財務レポート
財務データ
全年度
  • Form 10-Q - Q3 2025

    会計期末: 2025年9月30日|提出日: 2025年11月4日|
    売上高: $274.82M-2.0%
    |
    EPS: $0.03-90.6%
    予想を下回る
  • Form 10-Q - Q2 2025

    会計期末: 2025年6月30日|提出日: 2025年8月5日|
    売上高: $272.17M-3.4%
    |
    EPS: $0.43+43.3%
    予想を上回る
  • Form 10-Q - Q1 2025

    会計期末: 2025年3月31日|提出日: 2025年5月6日|
    売上高: $268.06M-4.9%
    |
    EPS: $-0.11-221.3%
    予想を下回る
  • Form 10-K - FY 2024

    会計期末: 2024年12月31日|提出日: 2025年2月24日|
    売上高: $1.13B-0.2%
    |
    EPS: $1.03+241.1%
    予想を上回る
  • Form 10-Q - Q3 2024

    会計期末: 2024年9月30日|提出日: 2024年11月7日|
    売上高: $280.49M+1.7%
    |
    EPS: $0.32-133.7%
    予想を上回る
  • Form 10-Q - Q2 2024

    会計期末: 2024年6月30日|提出日: 2024年8月8日|
    売上高: $281.70M-1.2%
    |
    EPS: $0.30+50.0%
    予想を上回る
  • Form 10-Q - Q1 2024

    会計期末: 2024年3月31日|提出日: 2024年5月6日|
    売上高: $281.73M+2.9%
    |
    EPS: $0.09-182.5%
    予想を上回る
  • Form 10-K - FY 2023

    会計期末: 2023年12月31日|提出日: 2024年2月27日|
    売上高: $1.13B+2.6%
    |
    EPS: $-0.73-9764.9%
    予想を下回る